# NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)

> **NCT06020664** · PHASE1 · SUSPENDED · sponsor: **NOxy Health Products, LLC** · enrollment: 30 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** NOX-1416+SOC
- **OTHER:** Placebo+SOC

## Key facts

- **NCT ID:** NCT06020664
- **Lead sponsor:** NOxy Health Products, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-08-16
- **Primary completion:** 2024-09
- **Final completion:** 2024-11-24
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** The NO-002 study had to be paused because of enrollment disruptions due to the current situation in Israel, and concerns over the placebo batch stability results.
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06020664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06020664, "NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06020664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*